RETRACTED: The Significance of PAX8-PPAR<i>γ</i> Expression in Thyroid Cancer and the Application of a PAX8-PPAR<i>γ</i>-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer

<div>Target molecular imaging in in vivo experiments after LIFU irradiation 1.40 w/cm<sup>2</sup> for 20 min.</div>

Contrast Media & Molecular Imaging

fig14

Figure 14

Figure 14: RETRACTED: The Significance of PAX8-PPAR<i>γ</i> Expression in Thyroid Cancer and the Application of a PAX8-PPAR<i>γ</i>-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer 

Figure 14 | RETRACTED: The Significance of PAX8-PPARγ Expression in Thyroid Cancer and the Application of a PAX8-PPARγ-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer 